<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04390620</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1912</org_study_id>
    <nct_id>NCT04390620</nct_id>
  </id_info>
  <brief_title>Assessment of DAFILON® Suture Material in Oral Surgery (Mucosal Sutures)</brief_title>
  <acronym>MUCODA</acronym>
  <official_title>Assessment of DAFILON® Suture Material in Oral Surgery (Mucosal Sutures). A Prospective, Single Arm Observational Study in Daily Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>B.Braun Surgical SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Aesculap AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this non-interventional study (NIS) a polyamide non-absorbable suture (Dafilon) will be&#xD;
      evaluated for oral surgery (mucosal closure after e.g. wisdom teeth extraction, implant&#xD;
      surgery, etc.) in adult patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this non-interventional study (NIS) a polyamide non-absorbable suture (Dafilon) will be&#xD;
      evaluated for oral surgery (mucosal closure after e.g. wisdom teeth extraction, implant&#xD;
      surgery, etc.) in adult patients.&#xD;
&#xD;
      The aim of this NIS is to collect systematically and proactively different clinical&#xD;
      parameters regarding safety, effectiveness and performance of Dafilon suture material under&#xD;
      the daily routine clinical practice when is intended to be used for oral surgery. All&#xD;
      patients enrolled will be prospectively followed until suture removal, which takes place 10 ±&#xD;
      5 days post-operatively (and post-operatively depending on routine clinical practice of each&#xD;
      hospital).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 6, 2020</start_date>
  <completion_date type="Actual">April 14, 2021</completion_date>
  <primary_completion_date type="Actual">April 7, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of combined postoperative complications Grade I and Grade II</measure>
    <time_frame>10 ± 5 days postoperatively (suture removal)</time_frame>
    <description>combined incidence of postoperative complications Grade I &amp; II on a Five Point scale defined by Askar et al. (Grade I: postoperative dentinal hypersensitivity / Oral candidiasis / Angular cheilitis / Exaggerated swelling defined as postoperative enlargement of tissues that exceeds the normal limits associated with a given surgical procedure / Delayed wound healing defined as an unusual deviation from the normal course of healing / Mild postoperative bleeding defined as the presence of small amount of blood in the oral cavity, usually mixed with saliva; Grade II: Flap dehiscence / Membrane exposure / Localized infection of the surgical site / Graft necrosis)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of individual postoperative complications</measure>
    <time_frame>until suture removal 10 ± 5 days postoperative</time_frame>
    <description>incidence of postoperative complications of Grade I - V on a Five Point scale defined by Askar et al. (Grade I &amp; II see Primary Outcome; Grade III: Fever / Skin rash / Neuropraxia/paresthesia / Trimus / Osteomyelitis / Septicemia / Sinusitis / Alveolar osteitis / Chymosis / Excessive and severe bleeding / Prolonged exaggerated swelling; Grade IV: Major complications that required immediate hospitalization such as drug induced anaphylaxis or septicemia; Grade V: Major complications that led to irreversible damage such neurotmesis and axonotmesis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessment using the visual analogue scale (VAS 1-100)</measure>
    <time_frame>at suture removal 10 ± 5 days postoperative</time_frame>
    <description>This parameter will be noted according to the Patient self assessment using the Visual Analogue Scale (VAS) which state &quot;0&quot; at one end representing &quot;no pain&quot; and &quot;100&quot; at the opposite end representing &quot;maximal pain&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of the patient using the visual analogue scale (VAS 1-100)</measure>
    <time_frame>at suture removal 10 ± 5 days postoperative</time_frame>
    <description>This parameter will be noted according to the Patient self assessment using the Visual Analogue Scale (VAS) which state &quot;0&quot; at one end representing &quot;completely satisfied&quot; and &quot;100&quot; at the opposite end representing &quot;not at all satisfied&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound healing assessment using the visual analogue scale (VAS 1-100)</measure>
    <time_frame>at suture removal 10 ± 5 days postoperative</time_frame>
    <description>This parameter will be noted by the surgeon using the Visual Analogue Scale (VAS) which state &quot;0&quot; at one end representing &quot;very good wound healing&quot; and &quot;100&quot; at the opposite end representing &quot;very bad wound healing&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>knot security</measure>
    <time_frame>intraoperative</time_frame>
    <description>Evaluation of Knot security with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tensile strength</measure>
    <time_frame>intraoperative</time_frame>
    <description>Evaluation of tensile strength with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>knot run down</measure>
    <time_frame>intraoperative</time_frame>
    <description>Evaluation of knot run down with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tissue drag</measure>
    <time_frame>intraoperative</time_frame>
    <description>Evaluation of tissue drag with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pliability</measure>
    <time_frame>intraoperative</time_frame>
    <description>Evaluation of pliability with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Bacterial contamination of the thread</measure>
    <time_frame>at suture removal 10 ± 5 days postoperative</time_frame>
    <description>optional</description>
  </other_outcome>
  <other_outcome>
    <measure>Pain assessment using the visual analogue scale (VAS 1-100)</measure>
    <time_frame>at follow-up up to five months postoperative</time_frame>
    <description>Optional: This parameter will be noted according to the Patient self assessment using the Visual Analogue Scale (VAS) which state &quot;0&quot; at one end representing &quot;no pain&quot; and &quot;100&quot; at the opposite end representing &quot;maximal pain&quot;.</description>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction of the patient using the visual analogue scale (VAS 1-100)</measure>
    <time_frame>at follow-up up to five months postoperative</time_frame>
    <description>Optional: This parameter will be noted according to the Patient self assessment using the Visual Analogue Scale (VAS) which state &quot;0&quot; at one end representing &quot;completely satisfied&quot; and &quot;100&quot; at the opposite end representing &quot;not at all satisfied&quot;.</description>
  </other_outcome>
  <other_outcome>
    <measure>Wound healing assessment using the visual analogue scale (VAS 1-100)</measure>
    <time_frame>at follow-up up to five months postoperative</time_frame>
    <description>Optional: This parameter will be noted by the surgeon using the Visual Analogue Scale (VAS) which state &quot;0&quot; at one end representing &quot;very good wound healing&quot; and &quot;100&quot; at the opposite end representing &quot;very bad wound healing&quot;.</description>
  </other_outcome>
  <other_outcome>
    <measure>Cosmetic outcome assessed by the physician using the visual analogue scale (VAS 1-100)</measure>
    <time_frame>at follow-up up to five months postoperative</time_frame>
    <description>Optional: This parameter will be noted by the surgeon using the Visual Analogue Scale (VAS) which state &quot;0&quot; at one end representing &quot;very good cosmetic outcome&quot; and &quot;100&quot; at the opposite end representing &quot;very bad cosmetic outcome&quot;.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">105</enrollment>
  <condition>Oral Surgery</condition>
  <condition>Tooth Extraction</condition>
  <condition>Dental Implants</condition>
  <arm_group>
    <arm_group_label>MUCODA</arm_group_label>
    <description>DAFILON - sterile, monofilament, non-absorbable surgical suture material produced from Polyamide</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mucosal Closure</intervention_name>
    <description>mucosal closure in oral surgery (mucosal sutures)</description>
    <arm_group_label>MUCODA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients undergoing mucosal wound closure using Dafilon as suture material in&#xD;
             oral surgery (in the event that more than one incision is performed in the same&#xD;
             patient, only one incision will be included).&#xD;
&#xD;
          -  Written informed consent regarding the data collection for the PMCF.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgery.&#xD;
&#xD;
          -  Oral surgery procedures requiring bone regeneration.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Patients taking medication that might affect wound healing.&#xD;
&#xD;
          -  Patients with hypersensitivity or allergy to the suture material.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nils Weyer, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Praxisklinik für Mund-, Kiefer- und Gesichtschirurgie Ästhetische und Plastische Chirurgie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Praxisklinik für Mund-, Kiefer- und Gesichtschirurgie, Ästhetische und Plastische Chirurgie</name>
      <address>
        <city>Esslingen am Neckar</city>
        <zip>73728</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitat Internacional de Catalunya (UIC)</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oral surgery</keyword>
  <keyword>mucosal closure</keyword>
  <keyword>complication rate</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

